Manager - In Licensing

Jubilant Bhartia Group Jubilant Bhartia Group is a global conglomerate founded by Mr. Shyam S Bhartia and Mr. Hari S Bhartia with strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services. Jubilant Bhartia Group has four flagships Companies- Jubilant Pharmova Limited, Jubilant Ingrevia Limited, Jubilant FoodWorks Limited and Jubilant Industries Limited. Currently the group has a global workforce of around 43,000 employees. Jubilant Pharmova Limited Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organization (CRDMO), Generics and Proprietary Novel Drugs businesses. In the Radiopharma business, the Company is involved in manufacturing and supply of Radiopharmaceuticals with a network of 46 radio-pharmacies in the US. The Company’s Allergy Immunotherapy business is involved in the manufacturing and supply of allergic extracts and venom products in the US and in some other markets such as Canada, Europe and Australia. Jubilant through its CDMO Sterile Injectables business offers manufacturing services including sterile fill and finish injectables (both liquid and lyophilization), full-service ophthalmic offer (liquids, ointments & creams) and ampoules. The CRDMO business of the Company includes the Drug Discovery Services business that provides contract research and development services through two world-class research centres in Bangalore and Noida in India and the CDMO-API business that is involved in the manufacturing of Active Pharmaceutical Ingredients. Jubilant Therapeutics is involved in Proprietary Novel Drugs business and is an innovative biopharmaceutical company developing breakthrough therapies in the area of oncology and autoimmune disorders. The company operates six manufacturing facilities that cater to all the regulated market including USA, Europe and other geographies. Find out more about us at: Company Profile (jubilantpharmova.com) Position Details: - Organization: Jubilant Generics Limited - Designation: Manager - In-Licensing - Location: Greater Noida - Job Summary: To generate business through collaboration with external partners through In- Licensing in line with strategic needs of the organization. Key Responsibilities: - Identification of Active Projects to fill the IL pipeline of Key Non US markets (GCC, South Africa): Map potential IL opportunities from partners across the globe and do market analysis and map potential business value for each opportunity. - Close and Drive Licensing deals for Non-US markets (GCC, South Africa): To in-license new products for Non-US markets of GCC and South Africa which are aligned to our strategic objectives. - Enabling consolidation of BD Status: To prepare Departmental Budget, Functional Review meetings, weekly and biweekly reports for respective markets. - Execution of ongoing Active In-licensing Projects: Managing alliance issues and interventions. Amendment creation and Execution. Person Profile: - Qualification: M. Pharma or B. Pharma with MBA (Intl. / Marketing). - Experience: 6-10 Years in large/midsized pharma companies having international exposure. - Desired function skills: Business case preparation (Excel etc.). Awareness about respective markets. Understanding of Legal agreements. - Desired behavioral skills: Interpersonal and Presentation skills. Jubilant is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to age, ancestry, citizenship, colour, gender identity or expression, genetic information, marital status, medical condition, national origin, political affiliation, race, ethnicity, religion or any other characteristic protected by applicable local laws, regulations and ordinances.